industry - Office of Continuing Professional Development
Oklahoma Chapter American College of Cardiology 2015 Annual Scien fic Mee ng Saturday, April 25, 2015 At the Samis Educa on Center Rainbolt Family Auditorium OUHSC Campus 1200 Children’s Avenue Oklahoma City, 73104 Program Chair C.A. Sivaram, M.D., F.A.C.P. Dear Colleagues, You are cordially invited to a end the 2015 Oklahoma Chapter American College of Cardiology Annual Scienfic Mee ng on Saturday, April 25, 2015. The mee ng site will be at the Rainbolt Family Auditorium in the Samis Educa on Center on the OUHSC campus. This exci ng program features speakers from both Oklahoma and outside. Please a end this session that provides a great opportunity to earn 6.00 AMA PRA Category 1 Credits™, listen to na onally renowned speakers, network with cardiac care providers from diverse communi es within the state and get to know cardiology fellows-in-training. Cardiovascular science is constantly evolving with both new discoveries and new therapies being published each year. This educa onal ac vity will provide cardiovascular professional team with an update on a selected number of high priority items iden fied from environmental scanning, with discussion of both the science and evidence behind current recommenda ons. The overall goal for this year’s conference is improvement of pa ent care through increasing learner competence that leads to improved performance in applying evidence based use of emerging treatment op ons. Topics emphasized at this session will include appropriate management of pa ents with valvular heart disease, guideline based selec on of pa ents for percutaneous mitral valve repair, evidence based use of pharmacologic therapy for heart failure, applica on of current guidelines in the management of hypercholesterolemia, awareness of new op ons of remote hemodynamic monitoring in heart failure and appropriate applica on of imaging modali es for detec on of myocardial viability. Chittur A. Sivaram, M.D. F.A.C.P.
SATURDAY, APRIL 25, 2015
C.A. Sivaram, M.D., F.A.C.P., Course Director and Moderator 7:30 a.m. 8:00 a.m. 8:05 a.m. 9:05 a.m. 10:05 a.m. 10:30 a.m. 11:30 a.m. 12:15 p.m. 1:00 p.m. Welcome and Housekeeping C.A. Sivaram, M.D., F.A.C.P 1:30 p.m. Controversies in Valvular Heart Disease Pat O’Gara, M.D., F.A.C.C. Recent Advances in Percutaneous 2:30 p.m. Mitral Valve Repair Samir Kapadia, M.D., F.A.C.C. Break 3:30 p.m. Visit Poster Session and Exhibits Recent Advances in Pharmacologic Therapy for Heart Failure Marvin Konstam, M.D., F.A.C.C. 4:30 p.m. Q & A with Dr. Pat O’Gara: The Status of Cardiology and the Future Direc on of the Cardiovascular Prac ce Registration, Continental Breakfast Visit Poster Session and Exhibits Lunch & General Body Mee ng Ted Mar n, M.D., F.A.C.P., presiding Visit Posters and Exhibits Update on Cholesterol Management: New Guidelines, New Recommenda ons and New Ques ons Andy Kates, M.D., F.A.C.C. Remote Hemodynamic Monitoring in Heart Failure Phil Adamson, M.D., F.A.C.C. Early Career Showcase: Myocardial Viability Assessment in the Management of Ischemic Heart Disease Nicole Tran, M.D. Wrap Up C.A. Sivaram, M.D., F.A.C.P. Accredita on Statement This ac vity has been planned and implemented in accordance with the accredita on requirements and policies of the Accredita on Council for Con nuing Medical Educa on (ACCME) through the joint providership of the University of Oklahoma College of Medicine and the Oklahoma Chapter of the American College of Cardiology. The University of Oklahoma College of Medicine is accredited by the ACCME to provide con nuing medical educa on for physicians. The University of Oklahoma College of Medicine designates this live ac vity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their par cipa on in the ac vity Conflict Resolu on Statement The University of Oklahoma College of Medicine, Oﬃce of Con nuing Professional Development has reviewed this ac vity’s speaker and planning commi ee disclosures and resolved all iden fied conflicts of interest, if applicable. Learner Objec ves Upon comple on of this mee ng, par cipants should accomplish improving physician competence by being able to: 1. Review the recent ACC/AHA Guidelines in the management of valvular heart disease 2. Iden fy the areas of controversy in the management of aor c stenosis and mitral regurgita on 3. Describe the applica on of guidelines to pa ent care using clinical vigne es 4. Iden fy the indica ons for surgery Mitral Regurgita on 5. Review the treatment op ons in func onal Mitral Regurgita on 6. Describe the treatment op ons in degenera ve Mitral Regurgita on 7. Review the appropriate use of pharmacologic treatment for heart failure 8. Iden fy the new evolving drug therapy op ons for heart failure 9. Describe the changes in recommenda ons in recently published guidelines on cholesterol treatment. 10. Iden fy the ques ons and controversies surrounding the new guidelines 11. Review recently published studies on lipid management 12. Iden fy the FDA approved use of implantable hemodynamic monitor systems 13. Review the scien fic basis for managing pa ents with implantable hemodynamic monitoring devices 14. Describe the expected clinical outcomes when appropriate pa ents are managed using implantable hemodynamic monitors 15. Review the data for the use of myocardial viability guided revasculariza on. 16. Contrast the pros and cons of the various imaging modali es used to evaluate myocardial viability including cardiac echocardiography, cardiac SPECT imaging, cardiac PET imaging and cardiac MRI. 17. Describe the clinical applica ons of myocardial viability assessment and a poten al strategy for incorpora on into clinical prac ce Planning Commi ee Program Director Chi ur A. Sivaram, M.D., F.A.C.P. David Ross Boyd Professor Vice Chief of Cardiovascular Sec on Director, Cardiology Fellowship Training Program—University of Oklahoma—OKC Where is the mee ng and where do I park? Ted Mar n, M.D., F.A.C.P. Governor, ACC Oklahoma Oklahoma Heart Ins tute—Tulsa, OK Faisal La f, M.D., F.A.C.C. Assistant Professor Cardiovascular Sec on University of Oklahoma—OKC Ma Cozart, M.D. (FIT member) Cardiovascular Fellow University of Oklahoma — OKC Kay Bickham Chapter Execu ve, ACC OK Chapter Course Contact Target Audience Adult Cardiologists, Pediatric Cardiologists, Cardiothoracic Surgeons, Cardiology Fellows-in-Training, the enre Cardiac Care Team including but not limited to: Nurses, Nurse Prac oners, Clinical Nurse Specialists, Physician Assistant, Pharmacists Overall Goal Statement The overall goal for this year’s conference is improving pa ent care through increasing learner knowledge, skills, a tudes and competence that leads to improved performance through applying evidence based care to pa ents with valvular heart disease, percutaneous repair of the mitral valve, heart failure, hypercholesterolemia and ischemic heart disease. Overall Need Statement Cardiovascular science is constantly evolving with both new discoveries and new therapies being published each year. This educa onal ac vity will provide the cardiovascular professional team with an update on a selected number of high priority items iden fied from environmental scanning, with discussion of both the science and the evidence behind current recommenda ons. Accommoda on Statement The University of Oklahoma is an equal opportunity ins tu on. www.ou.edu/eoo. Accommoda ons on the basis of disability are available by contac ng Kay Bickham at [email protected] Acknowledgement of Commercial and In‐Kind Support Commercial support is financial, or in-kind, contribu ons given by a commercial interest, which is used to pay all or part of the costs of a CME ac vity. A commercial interest is any en ty producing, marke ng, reselling, or distribu ng health care goods or services consumed by, or used on, pa ents. The ACCME does not consider providers of clinical service directly to pa ents to be commercial interests. This course is supported, in part, by educa onal grants from industry, in accordance with ACCME Standards. At this me, a complete lis ng of commercial supporters is not available. Appropriate acknowledgement will be given to all supporters at the me of the educa onal ac vity. Disclosure and COI Policy Statement ACC Chapter commi ee members, faculty, staﬀ and other individuals who are in a posi on to control the content of this ac vity are required to disclose all real or apparent conflicts of interest. All relevant poten al conflicts of interest that are iden fied are thoroughly ve ed through a process that includes course directors and appropriate peer review by educa on commi ee chairs/members, for fair balance, scien fic objecvity and validity, pa ent care and safety recommenda ons. Full disclosure will be published in the syllabus. Disclaimer Statement Statements, opinions and results of studies contained in the program are those of the presenters, authors and joint provider and do not reflect the policy or posi on of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability. Every reasonable eﬀort has been made to faithfully reproduce the presenta ons and material as submi ed. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or opera on of any methods, products, instruments or ideas contained in the material herein. Policy on Faculty, Presenters and Joint Provider Disclosure It is the policy of the University of Oklahoma College of Medicine that the faculty, presenters and joint provider disclose real or apparent conflicts of interest rela ng to the topics of this educa onal ac vity, and also disclose discussions of unlabeled/
unapproved uses of drugs or devices during their presenta on(s). Faculty Patrick O’Gara M.D., F.A.C.C. President of American College of Cardiology (2014-2015) Professor, Harvard Medical School Director of Clinical Cardiology Brigham and Women's Hospital Boston, MA Samir Kapadia M.D., F.A.C.C. Professor of Medicine Director of Sones’ Cardiac Catheteriza on Laboratory Director of Interven onal Cardiology Fellowship The Cleveland Clinic Founda on Cleveland, OH Marvin Konstam M.D., F.A.C.C. Professor of Medicine Chief, Division of Cardiology Past President of Heart Failure Society of America Tu s University Medical Center Boston, MA Andrew Kates M.D., F.A.C.C. Associate Professor, Cardiology Division Cardiology Fellowship Program Director Washington University at St. Louis Governor-elect, ACC Missouri Chapter St. Louis, MO Philip B. Adamson M.D., F.A.C.C. Director, Heart Failure Ins tute at Oklahoma Heart Hospital Adjunct Associate Professor of Physiology, University of Oklahoma Oklahoma City, OK Nicole Tran M.D. (Early Career Showcase) Assistant Professor of Medicine (Cardiovascular Sec on) University of Oklahoma Oklahoma City, OK REGISTRATION FORM (copy as needed) Earn up to 6.00 AMA PRA Category 1 CreditsTM FIRST NAME: _______________________LAST NAME: _____________________ TITLE (MD, RN, etc.) ____ ACC MEMBER ID #: ____________________ SPECIALITY ________________________________________ ADDRESS: ______________________________________ CITY: _________ STATE: ___ ZIP CODE:_____ PHONE: ________________________EMAIL: [email protected]__________________________ Saturday Scien fic Session $25 CME charge for Oklahoma Chapter members _____ including CCA members who want to claim CME Credits. _____ $95.00 for Physician Non Chapter members _____ $50.00 for CCA Non Chapter members _____ no charge for Resident/Medical Students TOTAL AMOUNT ENCLOSED $___________ ACC—Oklahoma Chapter 215 East Sixth Street www.okacc.org www.facebook.com/OklahomaACC Phone: 405 341-3169 Email: [email protected] Make check out to ACC, OK. Chapter Mail registra on form and payment to: Kay Bickham 215 East Sixth Street Edmond, OK. 73034 Or Email: [email protected] Or FAX to: 405 341-3173 www.okacc.org